Nick Colangelo News Today

CAMBRIDGE, Mass., May 22, 2024 -- Vericel Corporation , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO...

Key Insights Vericel's Annual General Meeting to take place on 1st of May Salary of US$790.0k is part of CEO Nick...

Company Provides Positive Outlook with Strong 2024 Revenue and EBITDA Margin Guidance

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0...

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% ...

CAMBRIDGE, Mass., Feb. 27, 2024 -- Vericel Corporation , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO...

Full-Year Total Revenue Expected to be Approximately $197.5 Million, Representing 20% Growth, with Fourth Quarter Revenue Growth of 23% to $65 Million MACI Full-Year Revenue Expected to be...

CAMBRIDGE, Mass., Jan. 03, 2024 -- Vericel Corporation , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO...

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Vericels Third Quarter 2023 conference call. At this time, all participants are in a listen-only mode.

Record Third Quarter Revenue of $45.6 Million, Representing 18% Growth versus Prior Year MACI Revenue Growth of 21% to $37.6 Million Full-Year...